![]() Adamis received his medical degree with honours from the University of Chicago Pritzker School of Medicine. ![]() Food and Drug Administration (FDA) across various indications. ![]() These development programmes led to 24 approvals by the U.S. ![]() He has guided the development of 20 medicines in global clinical trials involving more than 25,000 patients. Adamis is best known for co-discovering the central role of vascular endothelial growth factor (VEGF) in ocular vascular disease, including age-related macular degeneration (AMD) and diabetic retinopathy. Anthony (Tony) Adamis joined the board of directors of Gyroscope Therapeutics in December 2021.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |